People who are pregnant or lactating (PLP) have historically been excluded from research because of concerns for the developing fetus. But this has led to a dearth of data on new interventions against health threats for this population. In the case of HIV

2023 is a big year for PEPFAR. PEPFARs considered one of the greatest US foreign policy and global development achievements of the century; the program has saved upwards of 25 million lives since it launched in 2003. But PEPFAR is marking its 20th anni

With several large HIV vaccine trials in the last few years finding no efficacy, the field is in transition. There are diverse ideas in vaccine research, but there's no clear concept that's ready to test in a late-phase trial or move toward product develo

In March 2023, the Ugandan Parliament moved forward broad-reaching legislation to further criminalize LGBTQIA+ people.The bill would make it a crime to even identify as lesbian, gay, bisexual, transgender or queer, with sentences up to life imprisonmen

Over the coming months, global leaders will make key decisions about several initiatives to prepare for the next pandemic. What they commit to and how much they will spend, and how well these plans incorporate equity as a principle across all of these ini

Health leaders and advocates around the world are in the midst of creating a new architecture to deal with pandemics. This means new structures, systems and financing for pandemic prevention, preparedness and response — PPPR, for short. A lot is being dis

With all the talk about new HIV prevention products such as the dapivirine vaginal ring or injectable cabotegravir for PrEP, whats little understood is how to match proven products with programs, policies and the political will that's needed to get these

In this episode, AVACs Jeanne Baron and co-host immunologist Katharine Kripke of AVENIR Health explore why developing a vaccine for HIV is different from other viruses. Two vaccine researchers, Caltechs Pamela Bjorkman and IAVIs Vincent Kioi, lend the

Linda-Gail Bekker from South Africas Desmond Tutu Health Foundation and Lillian Mworeko from the International Community of Women Living with HIV East Africa (ICWEA) join host Jeanne Baron and AVACs Executive Director Mitchell Warren to discuss innovat

Endpoints are a crucial component in every clinical trial but they are not always well understood, and putting them in context is essential for effective advocacy. This next installment of the Px Pulse series, Research Fundamentals, which explores key sc